Plain-English translation of NCT07905053 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Australia
Safety & dosing
Sponsor
Cibus Therapeutics, Inc.
Collaborators
Avance Clinical Pty Ltd.
Enrollment target
~32 participants
Started
October 2026
Primary completion
May 2027
Age range
18 Years – 55 Years
Last updated on clinicaltrials.gov in October 2026.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.